LIGAND PHARMACEUTICALS INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 3.04 thousand shares for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2017-11-09
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2017-09-30 was 3.04K shares, a 47.81% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2017-06-30 was 0.00 shares.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2017-03-31 was 0.00 shares.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2016-09-30 was 5.83K shares.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2014 was 4.46K shares, a 84.49% decline from fiscal 2013.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2013 was 28.78K shares, a 1.34% decline from fiscal 2012.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2012 was 29.17K shares, a 61.07% decline from fiscal 2011.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2011 was 74.94K shares, a 48.39% decline from fiscal 2010.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2017-09-30 | 3.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 3.04K shares derived: sum of 2 quarters · filed 2017-11-09 | 3.04K shares 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 0.00 shares 10-Q · filed 2017-08-09 | |||
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-09 | ||||
| 2016-09-30 | 5.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 30.11K shares 10-Q · filed 2016-11-14 | |||
| 2016-06-30 | 24.28K shares 10-Q · filed 2016-11-14 | ||||
| 2014-12-31 | 50.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | 650.00 shares derived: sum of 2 quarters · filed 2015-02-23 | 3.02K shares derived: sum of 3 quarters · filed 2015-02-23 | 4.46K shares 10-K · filed 2015-02-23 | 28.78K shares 10-K · filed 2014-12-01 |
| 2014-09-30 | 600.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | 2.97K shares derived: sum of 2 quarters · filed 2014-10-31 | 4.41K shares 10-Q · filed 2014-10-31 | 5.41K shares derived: sum of 4 quarters · filed 2014-12-12 | |
| 2014-06-30 | 2.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | 3.81K shares 10-Q · filed 2014-08-05 | 4.81K shares derived: sum of 3 quarters · filed 2014-12-12 | 4.81K shares derived: sum of 4 quarters · filed 2014-12-12 | |
| 2014-03-31 | 1.44K shares 10-Q · filed 2014-05-07 | 2.44K shares derived: sum of 2 quarters · filed 2014-12-12 | 2.44K shares derived: sum of 3 quarters · filed 2014-12-12 | 6.10K shares derived: sum of 4 quarters · filed 2014-12-12 | |
| 2013-12-31 | 999.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | 999.00 shares derived: sum of 2 quarters · filed 2014-12-12 | 4.66K shares derived: sum of 3 quarters · filed 2014-12-12 | 28.78K shares 10-K/A · filed 2014-12-12 | |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | 3.66K shares derived: sum of 2 quarters · filed 2013-11-08 | 27.78K shares 10-Q · filed 2013-11-08 | 43.47K shares derived: sum of 4 quarters · filed 2014-12-12 | |
| 2013-06-30 | 3.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | 27.78K shares 10-Q · filed 2013-08-01 | 43.47K shares derived: sum of 3 quarters · filed 2014-12-12 | 44.13K shares derived: sum of 4 quarters · filed 2014-12-12 | |
| 2013-03-31 | 24.12K shares 10-Q · filed 2013-05-08 | 39.81K shares derived: sum of 2 quarters · filed 2014-12-12 | 40.47K shares derived: sum of 3 quarters · filed 2014-12-12 | ||
| 2012-12-31 | 15.69K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | 16.35K shares derived: sum of 2 quarters · filed 2014-12-12 | 29.17K shares 10-K/A · filed 2014-12-12 | ||
| 2012-09-30 | 658.00 shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | 13.48K shares 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | 12.82K shares 10-Q/A · filed 2012-11-14 | ||||
| 2011-12-31 | 74.94K shares 10-K/A · filed 2014-12-12 | ||||
| 2010-12-31 | 145.21K shares 10-K · filed 2013-03-14 |